Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN) - Yahoo Finance

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

What’s in a List? EPA Eyes PFAS, Pharmaceuticals and Microplastics in Drinking Water - Williams Mullen

news.google.com · 09 Sep 2026

Google News – FDA (biotech/pharma) External News

UCB’s Cimzia wins FDA Breakthrough therapy status for antiphospholipid syndrome - thepharmaletter.com

news.google.com · 09 Sep 2026

Google News – Oncology External News

Merck pairs ADCs with Keytruda in women’s cancer push - Pharma Voice

news.google.com · 09 Sep 2026

Google News – Biopharma External News

AEON Biopharma, Inc. Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of Abp-450 to Botox - marketscreener.com

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN - PR Newswire

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Transcript : Regeneron Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08 - marketscreener.com

news.google.com · 09 Sep 2026

Google News – Biotech Funding External News

Karimah Es Sabar Joins Linearis Ventures as Strategic Life Sciences and Venture Capital Advisor - Yahoo Finance

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - Investing.com

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

The Transition to Home: Why Confidence is Critical to Patient Success - Pharmaceutical Commerce

news.google.com · 09 Sep 2026

Google News – Oncology External News

Urogen Pharma: Upside After Bladder Cancer Launch (NASDAQ:URGN) - Seeking Alpha

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia - BioSpace

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Kaplan Fox Deadline Alert: ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Have Until October 5, 2026 to Seek a Lead Plaintiff Role - NewMediaWire

news.google.com · 09 Sep 2026

Google News – Biotech Funding External News

GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing - Fierce Biotech

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Recursion Pharmaceuticals Stock Short Interest Falls to 34.79% - Quiver Quantitative

news.google.com · 09 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN) - Yahoo Finance

What’s in a List? EPA Eyes PFAS, Pharmaceuticals and Microplastics in Drinking Water - Williams Mullen

UCB’s Cimzia wins FDA Breakthrough therapy status for antiphospholipid syndrome - thepharmaletter.com

Merck pairs ADCs with Keytruda in women’s cancer push - Pharma Voice

AEON Biopharma, Inc. Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of Abp-450 to Botox - marketscreener.com

Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN - PR Newswire

Transcript : Regeneron Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08 - marketscreener.com

Karimah Es Sabar Joins Linearis Ventures as Strategic Life Sciences and Venture Capital Advisor - Yahoo Finance

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - Investing.com

The Transition to Home: Why Confidence is Critical to Patient Success - Pharmaceutical Commerce

Urogen Pharma: Upside After Bladder Cancer Launch (NASDAQ:URGN) - Seeking Alpha

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia - BioSpace

Kaplan Fox Deadline Alert: ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Have Until October 5, 2026 to Seek a Lead Plaintiff Role - NewMediaWire

GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing - Fierce Biotech

Recursion Pharmaceuticals Stock Short Interest Falls to 34.79% - Quiver Quantitative